Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in India, following approval by the Central Drugs Standard Control Organisation.
Natco Pharma shares slipped in trade after the company said that the USFDA has issued one (1) observation in the Form-483 for its API manufacturing plant in Mekaguda, Hyderabad.
Sun Pharma shares dropped in trade after the company announced that United States Food and Drug Administration (USFDA) has issued a Form-483, with 8 observations for its Halol facility in Gujarat.
Jubilant Pharmova shares rose after its board approved the slump sale of its API business to wholly-owned subsidiary, Jubilant Biosys.
The stock of the pharmaceutical company Eris Lifesciences was trading higher for the third straight day, soaring 17 per cent during the period.
The Nifty Pharma index and select shares such as Biocon, Cipla, Zydus Life and Gland Pharma were trading above the respective 200-DMAs after more than 2 months; show technical charts.
Shares of Wockhardt hit an all-time high of ₹1,809.95, as they rallied 17% on the BSE in Wednesday's intra-day trade surpassed its previous high of ₹1,678.60 touched on February 6, 2025.
Marksans Pharma shares rose 5 per cent after 10.27 million shares changed hands via multiple pre-market block trades
Shares of OneSource Specialty Pharma hit a new high of ₹2,031.45 in Tuesday's intra-day trade in otherwise a subdued market and rallied 28% in the past month
In the US market, robust growth in the base portfolio, new launches and generic version of Myrbetriq (for overactive bladder) aided its revenue effort in that market
Gland Pharma shares rose after it secured United States Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA) for Angiotensin II Acetate Injection 2.5 mg/mL.
Biocon's share price saw an uptick following key regulatory approvals in India for its Liraglutide drug, which is used in the treatment of type 2 diabetes.
AstraZeneca Pharma shares rose on receiving nod from the CDSCO, to import for sale and distribution of Benralizumab 30 mg/ml solution for injection (brand name: Fasenra) for an additional indication.
Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
Natco Pharma share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
Abbott India, Aurobindo Pharma, Cipla, Dr Lal PathLabs and Torrent Pharma flag caution signals on technical charts; here are the key levels to watch out for.
Bajaj Healthcare share price dropped today on the back of weak operational performance in the March quarter of FY25 (Q4FY25).
Divi's Laboratories share price rose after the company announced that it has inked a long-term manufacturing and supply agreement with a global pharmaceutical company.
Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets USP, 200 mg - a generic version of Zyloprim 200 mg by Casper Pharma LLC.
The Sensex settled at 81,596.63, up 410.19 points or 0.51 per cent, while the Nifty50 closed at 24,813.45, gaining 129.55 points or 0.52 per cent